Pelthos Therapeutics Inc. (PTHS) Operating income 2022–2025
Pelthos Therapeutics Inc. (PTHS) annual operating income history from SEC filings — each fiscal year as reported.
-$32.4MFY2025 · since FY2022: -$2.3M → -$32.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.4M | -328.3% |
| FY2024 | -$7.6M | -10.3% |
| FY2023 | -$6.9M | -196.0% |
| FY2022 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTHS financial trends
PTHS RevenuePTHS Net incomePTHS Net marginPTHS Gross profitPTHS Gross marginPTHS Operating marginPTHS Operating cash flowPTHS Free cash flowPTHS Capital expendituresPTHS Return on equityPTHS Stock buybacksPTHS Dividends paidPTHS Total assetsPTHS Total liabilitiesPTHS Shareholders’ equityPTHS overview →